A rising number of people microdose psychedelics in pursuit of mental health benefits. Yet, the science hasn’t caught up with its popularity ...

Magic mushroom research reveals that their effects are not so much about hallucinations but about a less-inhibited self.

Psilocybin significantly reduces confidence in negative self-beliefs four weeks after administration, with effects linked to ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Recent years have seen growing interest in psychedelic-assisted therapies as potential alternatives or complements to ...

A class of illegal drugs can help with mental health issues for some — is awe the key to psychedelic medicine?

Anxiety and depression are the most common ways cancer can affect ... Recently, a growing movement is interested in ...

Cybin has unveiled phase 2 results with its psychedelic medicine for major ... and clinically significant” improvement in depression symptoms after a single 12 mg dose in the study, said the ...

PsychedeliCare, a movement that includes health care professionals, academics and advocates, launched the psychedelic therapy ...

After voters rejected a ballot question that would have legalized some psychedelics ... end-of-life stress and depression. Scituate Rep. Patrick Kearney filed another bill (HD 1003) that would ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, an analyst ...